Enterprise Value
486.3M
Cash
210.7M
Avg Qtr Burn
-47.89M
Short % of Float
25.64%
Insider Ownership
26.27%
Institutional Own.
66.05%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PM359 Details Chronic granulomatous disease | Phase 1/2 Initiation |